My direct take: I followed this profile personally and wanted to leave context, not only stars. I stayed in for roughly 80 days, then exited. I entered with approximately USD 22,660, and the recent mark shows about USD 17,674.80. I am down about -USD 4,985.20 (22.00%) currently, though downside was managed professionally. Weekly context helped me understand why pacing changed. I expected tighter drawdown control than what I experienced. I would not recommend this for conservative users at the moment. Good structure, with room for slightly cleaner timing in choppy markets. A few entries felt late, especially after momentum was already extended. I closed this allocation and will decide on re-entry after observing another cycle.

Quick context first: Posting this because I wanted to show what the cycle felt like. I followed for around 72 days before redeeming and closing the cycle. Current drawdown is about -USD 89.64 (12.00%), but risk handling remained disciplined. I committed around USD 747, and the current valuation is roughly USD 657.36. Drawdown handling appeared intentional and measured. I could understand why positions were opened, trimmed, or closed. I appreciated that weaker trades were reported openly, not hidden. Market conditions were not easy during this period, so process quality mattered more to me than a single snapshot result. Now that I exited, I would still consider re-entry in a future cycle.

My direct take: I do not usually write long reviews, but this one should help others. I followed for around 19 days before redeeming and closing the cycle. So far it translates to about +USD 9,674.08 (52.00%), without unusual risk spikes. I committed around USD 18,604, and the current valuation is roughly USD 28,278.08. Execution quality stayed fairly consistent even during fast sessions. Reporting quality made it easier to stay objective through volatility. Capital preservation clearly remained part of the decision framework. Market conditions were not easy during this period, so process quality mattered more to me than a single snapshot result. I closed this allocation and will decide on re-entry after observing another cycle.

Based on my own allocation, I kept notes through this cycle, so this review is based on actual observations. I stayed in for roughly 17 days, then exited. I entered with approximately USD 1,750, and the recent mark shows about USD 2,485.00. At this stage I am up roughly +USD 735.00 (42.00%), which fits the stated risk profile. Comments around invalidation and risk reductions were practical. Position management looked deliberate, especially around volatile hours. Exposure was not pushed beyond what felt reasonable for this profile. After redeeming, I would classify this as disciplined but mixed.

Quick context first: I kept notes through this cycle, so this review is based on actual observations. I am around 173 days into this cycle and still invested. I entered with approximately USD 23,111, and the recent mark shows about USD 22,879.89. Current drawdown is about -USD 231.11 (1.00%), but risk handling remained disciplined. I appreciated that weaker trades were reported openly, not hidden. Execution quality stayed fairly consistent even during fast sessions. Drawdown handling appeared intentional and measured. Market conditions were not easy during this period, so process quality mattered more to me than a single snapshot result. I am keeping the allocation active for now and will review again next month.

Quick context first: I followed this profile personally and wanted to leave context, not only stars. I am around 20 days into this cycle and still invested. I entered with approximately USD 15,483, and the recent mark shows about USD 24,153.48. Net outcome is around +USD 8,670.48 (56.00%), and the path there felt controlled. Overall, I would shortlist this agent again for a similarly sized allocation. Drawdown handling appeared intentional and measured. I appreciated that weaker trades were reported openly, not hidden. I tracked this weekly against my own notes, not just daily PnL screenshots. I am keeping the allocation active for now and will review again next month.